Roger Waltzman

Company: Molecular Templates

Job title: Chief Medical Officer

Seminars:

Novel Immunotoxin MT-5111 in Avoiding Competition With & Overcoming the Primary Mechanisms of Tumor Resistance to Current HER2-Targeted Therapies 11:30 am

• Exploring the drug discovery process: target identification and validation, antitumor effect, pathway understanding, biomarkers • Discussing potential indications • Discussing the biomarker and patient status • Latest data and future directionsRead more

day: Day Two